Highbridge Capital Management’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-144,456
| Closed | -$290K | – | 481 |
|
|
2023
Q1 | $290K | Sell |
144,456
-1
| -0% | -$3 | 0.01% | 184 |
|
|
2022
Q4 | $527K | Buy |
144,457
+1
| +0% | +$4 | 0.01% | 257 |
|
|
2022
Q3 | $534K | Buy |
144,456
+825
| +0.6% | +$5.86K | 0.01% | 373 |
|
|
2022
Q2 | $900K | Buy |
143,631
+84,827
| +144% | +$792K | 0.02% | 348 |
|
|
2022
Q1 | $665K | Buy |
+58,804
| New | +$750K | 0.02% | 403 |
|
|
2021
Q1 | – | Sell |
-926
| Closed | -$45K | – | 196 |
|
|
2020
Q4 | $45K | Buy |
+926
| New | +$34.8K | ﹤0.01% | 116 |
|
|
2019
Q4 | – | Sell |
-14,260
| Closed | -$153K | – | 81 |
|
|
2019
Q3 | $153K | Sell |
14,260
-27,671
| -66% | -$246K | 0.02% | 69 |
|
|
2019
Q2 | $331K | Sell |
41,931
-42
| -0.1% | -$428 | 0.02% | 145 |
|
|
2019
Q1 | $579K | Sell |
41,973
-6,335
| -13% | -$73.4K | 0.02% | 305 |
|
|
2018
Q4 | $394K | Buy |
+48,308
| New | +$846K | 0.01% | 327 |
|
|
2018
Q1 | – | Sell |
-14,692
| Closed | -$672K | – | 1847 |
|
|
2017
Q4 | $672K | Sell |
14,692
-1,975
| -12% | -$105K | 0.01% | 743 |
|
|
2017
Q3 | $1.03M | Buy |
16,667
+1,018
| +7% | +$59.6K | 0.02% | 583 |
|
|
2017
Q2 | $993K | Buy |
15,649
+2,228
| +17% | +$123K | 0.01% | 570 |
|
|
2017
Q1 | $998K | Buy |
+13,421
| New | +$1.49M | 0.01% | 626 |
|
Highbridge Capital Management's NH Position: Q2 2023 in Review
Highbridge Capital Management sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 144,456 shares — an estimated $290K sold.
Highbridge Capital Management first reported a position in NH in Q1 2017 and held it in 14 quarters. The position peaked at $1.03M in Q3 2017. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Highbridge Capital Management reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Highbridge Capital Management sold 144,456 NantHealth, Inc shares in Q2 2023, an estimated $290K.
- Highbridge Capital Management first reported a position in NantHealth, Inc in Q1 2017 and held it in 14 quarters.
- Highbridge Capital Management's NantHealth, Inc position peaked at $1.03M in Q3 2017.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Highbridge Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.